Mytrang H Do Selected Research

Mytrang H Do Research Topics

9	Neoplasms (Cancer) 04/2024 - 01/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 11/2020
2	Infections 12/2021 - 01/2021
1	Hypersensitivity (Allergy) 04/2024
1	Hypoxia (Hypoxemia) 11/2023
1	Tuberous Sclerosis (Bourneville's Disease) 11/2023
1	Melanoma (Melanoma, Malignant) 11/2020
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020
1	Starvation 11/2020
1	Merkel Cell Carcinoma 11/2020
1	COVID-19 07/2020
1	Coinfection 01/2020

4	Mechanistic Target of Rapamycin Complex 1IBA 04/2024 - 01/2020
2	GTP Phosphohydrolases (GTPases)IBA 07/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 11/2020
2	Transforming Growth Factor-beta Type II ReceptorIBA 11/2020 - 11/2020
1	Leucine (L-Leucine)FDA Link 04/2024
1	Endothelial Protein C ReceptorIBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 07/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	cyclopropapyrroloindoleIBA 12/2021
1	AntigensIBA 01/2021
1	cemiplimabIBA 11/2020
1	pembrolizumabIBA 11/2020
1	IpilimumabIBA 11/2020
1	NivolumabIBA 11/2020
1	avelumabIBA 11/2020
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	CytokinesIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	SmokeIBA 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	VaccinesIBA 01/2016

5	Therapeutics 07/2023 - 11/2020
4	Immunotherapy 11/2023 - 01/2016
1	Protein-Restricted Diet (Diet, Protein Restricted) 07/2023
1	Phototherapy (Light Therapy) 11/2020
1	Dermatologic Surgical Procedures 07/2020
1	Personal Protective Equipment 07/2020